7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Carcinoma D002277 18 associated lipids
Albuminuria D000419 18 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Wounds and Injuries D014947 20 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
HIV Infections D015658 20 associated lipids
Cachexia D002100 21 associated lipids
Myocardial Infarction D009203 21 associated lipids
Periodontitis D010518 22 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Jung YJ et al. Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. 2017 Mol Oral Microbiol pmid:27484636
Kuroyanagi G et al. (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. 2017 Prostaglandins Other Lipid Mediat. pmid:28163121
Chen X et al. Emodin suppresses cadmium-induced osteoporosis by inhibiting osteoclast formation. 2017 Environ. Toxicol. Pharmacol. pmid:28738286
Shetelig C et al. Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. 2017 PLoS ONE pmid:28253327
Irtyuga O et al. NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. 2017 Biomed Res Int pmid:28246602
Hanmoto T et al. Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. 2017 Biomed. Res. pmid:28239034
Fioramonti M et al. Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. 2017 Oncotarget pmid:28223547
Xiong L et al. Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. 2017 J. Cell Biol. pmid:28193701
Fortner RT et al. Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. 2017 BMC Med pmid:28173834
Chung ST et al. Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. 2017 Mol. Cancer pmid:28143606

Table of Content